Prof. Dr. med. Carola Berking



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

The proportion of circulating CD45RO+CD8+ memory T cells is correlated with clinical response in melanoma patients treated with ipilimumab (2017) Tietze JK, Angelova D, Heppt MV, Reinholz M, Murphy WJ, Spannagl M, Ruzicka T, Berking C Journal article Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: A multicenter randomized phase-3 DeCOG trial (2017) Ugurel S, Loquai C, Terheyden P, Schadendorf D, Richtig E, Utikal J, Gutzmer R, et al. Journal article Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe (2017) Becker JC, Lorenz E, Ugurel S, Eigentler TK, Kiecker F, Pfoehler C, Kellner I, et al. Journal article Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review. (2017) Heppt MV, Steeb T, Schlager JG, Rosumeck S, Dressler C, Ruzicka T, Nast A, Berking C Journal article, Review article Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition (2017) Heppt MV, Heinzerling L, Kaehler KC, Forschner A, Kirchberger MC, Loquai C, Meissner M, et al. Journal article Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy (2016) Hofmann L, Forschner A, Loquai C, Goldinger SM, Zimmer L, Ugurel S, Schmidgen MI, et al. Journal article Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial (2016) Leiter U, Stadler R, Mauch C, Hohenberger W, Brockmeyer N, Sunderkoetter C, Kaatz M, et al. Journal article Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy (2016) Zimmer L, Goldinger SM, Hofmann L, Loquai C, Ugurel S, Thomas I, Schmidgen MI, et al. Journal article SOX10 promotes melanoma cell invasion by regulating melanoma inhibitory activity (2014) Graf SA, Busch C, Besch R, Berking C, Bosserhoff AK Journal article